Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0IE4H
|
||||
Former ID |
DIB003557
|
||||
Drug Name |
TAZOMELINE
|
||||
Synonyms |
Hexylthio-TZTP; LY-287041; Tazomeline < Prop INN; NNC-11-0309; 3-[3-(Hexylthio)-1,2,5-thiadiazol-4-yl]-1-methyl-1,2,5,6-tetrahydropyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cognitive disorders [ICD9: 290-294, 294.0, 780.09, 780.9, 780.93; ICD10:F01-F07, F04, F05, R41.3] | Discontinued in Phase 1 | [546138] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H23N3S2
|
||||
Canonical SMILES |
CCCCCCSc1nsnc1C2=CCCN(C)C2
|
||||
InChI |
1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3
|
||||
InChIKey |
XUHMGFKQBWZWPO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 131987-54-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Agonist | [551871] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.